EIF3E Peptide | 42-702P

EIF3E Peptide | 42-702P | Gentaur UK, US & Europe Distribution

Short Description: (CT) EIF3E Peptide

Species: Human

Location: EIF3E peptide is a synthetic peptide corresponding to the C Terminus of EIF3E.

Tested Application: Bl

Application: EIF3E Peptide is used for blocking the activity of EIF3E antibody (catalog number 42-702). The EIF3E antibody ships at 0.5 mg/mL and the EIF3E Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.

Physical State: Lyophilized

Buffer: EIF3E peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL.

Concentration: N/A

Storage: Store at -20˚C. When reconstituted minimize freezing and thawing.

NCBI Official Symbol: EIF3E

Alternate Names: INT6, EIF3S6, EIF3-P48, eIF3-p46, INT6, Eukaryotic translation initiation factor 3 subunit E, Eukaryotic translation initiation factor 3 subunit 6, eIF3e

NCBI Gene ID: 3646

User Note: N/A

NCBI Official Name: Eukaryotic Translation Initiation Factor 3, Subunit E

Background: N/A

Disclaimer: This product is for research use only.